NASDAQ:JUNS
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc.'s revenue was $21,796 in fiscal 2025. The diluted share count rose 20.3%.Summary generated from Jupiter Neurosciences, Inc.'s SEC filings. Latest annual report filed Apr 1, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$21,796
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross margin80.6%
Operating margin−40873.2%
Net margin−39662.8%
ROICn/a
Return on equity−738.8%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+20.3%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | n/a | 0 | 0 |
| Operating income | −4 | −3 | −9 |
| Net income | −5 | −2 | −9 |
| Free cash flow | n/a | n/a | n/a |
Recent filings
- 8-KAmendment to articles or bylaws
Sep 3, 2026 - 8-KNotice of delisting or listing-rule failure
Aug 28, 2026 - 8-KEntry into a material agreement
Aug 27, 2026 - 8-KOther events
Aug 24, 2026 - 8-KEntry into a material agreement
Aug 24, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KAmendment to articles or bylaws
Aug 6, 2026 - 4Insider transaction report
Aug 5, 2026